This study presents a cost-effectiv

This
study presents
a
cost-effectiveness
analysis
from
a
third
party
payer's
perspective
using
a
Warkov-model.
Four
different
strategies
in
the management
of
hypertension
in
young
male
patients without established
cardiovascular
disease
who
are about
to
start
antihypertensive
dmg
therapy are compared:
1.
Treat
everybody
with
conventional therapy
(beta-blockers
or
diuretics),
2.
Treat everybody with
an
ACE-inhibitor,
3.
Individualize
antihypertensive
ihenpy
according
to
the presence
or
absence
of
left
ventricular
hypertrophy
on
electrocardiography.
or
4.
Individualize
therapy according
to
the
presencr
or
absence
of
leR
ventricular
hypertrophy
on
echocardiography.
The results
of
the
mode1
show
that
XE-inhibi
tors
cannot
be
recommended
as
antihypertensive
first-line
therapy
in
these
patients
unless they
becorne
markedly
cheaper
because
the
ACE-inhibitor
associated
gain
in
unadjusted
and
quality-adjusted
life-years
is
small
and
clinically
not
relevant. Prescribiny
conventional
antihypertensive
therapy
to
everybody
or
performing routine
ECG
to
individualize treatment
can
be
recommended
as
strategies of
choice.
Funher
studies
are
needed
to
mess
the
role
of
routine echocardiography.

This 
study presents 
a 
cost-effectiveness 
analysis 
from 
a 
third 
party 
payer's 
perspective 
using 
a 
Warkov-model. 
Four 
different 
strategies 
in 
the management 
of 
hypertension 
in 
young 
male 
patients without established 
cardiovascular 
disease 
who 
are about 
to 
start 
antihypertensive 
dmg 
therapy are compared: 
1. 
Treat 
everybody 
with 
conventional therapy 
(beta-blockers 
or 
diuretics), 
2. 
Treat everybody with 
an 
ACE-inhibitor, 
3. 
Individualize 
antihypertensive 
ihenpy 
according 
to 
the presence 
or 
absence 
of 
left 
ventricular 
hypertrophy 
on 
electrocardiography. 
or 
4. 
Individualize 
therapy according 
to 
the 
presencr 
or 
absence 
of 
leR 
ventricular 
hypertrophy 
on 
echocardiography. 
The results 
of 
the 
mode1 
show 
that 
XE-inhibi 
tors 
cannot 
be 
recommended 
as 
antihypertensive 
first-line 
therapy 
in 
these 
patients 
unless they 
becorne 
markedly 
cheaper 
because 
the 
ACE-inhibitor 
associated 
gain 
in 
unadjusted 
and 
quality-adjusted 
life-years 
is 
small 
and 
clinically 
not 
relevant. Prescribiny 
conventional 
antihypertensive 
therapy 
to 
everybody 
or 
performing routine 
ECG 
to 
individualize treatment 
can 
be 
recommended 
as 
strategies of 
choice. 
Funher 
studies 
are 
needed 
to 
mess 
the 
role 
of 
routine echocardiography.

0/5000

From: -

To: -

Results (Indonesian) 1: [Copy]

Copied!

This study presents a cost-effectiveness analysis from a third party payer's perspective using a Warkov-model. Four different strategies in the management of hypertension in young male patients without established cardiovascular disease who are about to start antihypertensive dmg therapy are compared: 1. Treat everybody with conventional therapy (beta-blockers or diuretics), 2. Treat everybody with an ACE-inhibitor, 3. Individualize antihypertensive ihenpy according to the presence or absence of left ventricular hypertrophy on electrocardiography. or 4. Individualize therapy according to the presencr or absence of leR ventricular hypertrophy on echocardiography. The results of the mode1 show that XE-inhibi tors cannot be recommended as antihypertensive first-line therapy in these patients unless they becorne markedly cheaper because the ACE-inhibitor associated gain in unadjusted and quality-adjusted life-years is small and clinically not relevant. Prescribiny conventional antihypertensive therapy to everybody or performing routine ECG to individualize treatment can be recommended as strategies of choice. Funher studies are needed to mess the role of routine echocardiography.

Being translated, please wait..

Results (Indonesian) 2:[Copy]

Copied!

Ini
studi menyajikan
sebuah
efektivitas biaya
analisis
dari
sebuah
ketiga
pihak
pembayar
perspektif
menggunakan
sebuah
. Warkov model
Four
berbeda
strategi
dalam
pengelolaan
dari
hipertensi
di
muda
laki-laki
pasien tanpa didirikan
kardiovaskular
penyakit
yang
sekitar
untuk
memulai
antihipertensi
dmg
terapi dibandingkan:
1.
Perlakukan
semua orang
dengan
terapi konvensional
(beta-blocker
atau
diuretik),
2.
Perlakukan setiap orang dengan
sebuah
ACE-inhibitor,
3.
individualize
antihipertensi
ihenpy
sesuai
dengan
kehadiran
atau
tidak adanya
dari
kiri
ventrikel
hipertrofi
pada
elektrokardiografi.
atau
4.
individualize
terapi sesuai
dengan
yang
presencr
atau
tidak adanya
dari
Ler
ventrikel
hipertrofi
pada
echocardiography.
hasil
dari
para
Mode1
acara
yang
XE-inhibi
tor
tidak dapat
dapat
direkomendasikan
sebagai
antihipertensi
lini pertama
terapi
di
ini
pasien
kecuali mereka
becorne
nyata
lebih murah
karena
yang
ACE-inhibitor
terkait
gain
di
disesuaikan
dan
kualitas-disesuaikan
hidup -years
adalah
kecil
dan
klinis
tidak
relevan. Prescribiny
konvensional
antihipertensi
terapi
untuk
semua orang
atau
melakukan rutinitas
EKG
untuk
individualize pengobatan
dapat
dilakukan
direkomendasikan
sebagai
strategi
pilihan.
Funher
studi
yang
diperlukan
untuk
mess
dengan
peran
dari
echocardiography rutin.

Being translated, please wait..

Results (Indonesian) 3:[Copy]

Copied!

Being translated, please wait..

Other languages

The translation tool support: Afrikaans, Albanian, Amharic, Arabic, Armenian, Azerbaijani, Basque, Belarusian, Bengali, Bosnian, Bulgarian, Catalan, Cebuano, Chichewa, Chinese, Chinese Traditional, Corsican, Croatian, Czech, Danish, Detect language, Dutch, English, Esperanto, Estonian, Filipino, Finnish, French, Frisian, Galician, Georgian, German, Greek, Gujarati, Haitian Creole, Hausa, Hawaiian, Hebrew, Hindi, Hmong, Hungarian, Icelandic, Igbo, Indonesian, Irish, Italian, Japanese, Javanese, Kannada, Kazakh, Khmer, Kinyarwanda, Klingon, Korean, Kurdish (Kurmanji), Kyrgyz, Lao, Latin, Latvian, Lithuanian, Luxembourgish, Macedonian, Malagasy, Malay, Malayalam, Maltese, Maori, Marathi, Mongolian, Myanmar (Burmese), Nepali, Norwegian, Odia (Oriya), Pashto, Persian, Polish, Portuguese, Punjabi, Romanian, Russian, Samoan, Scots Gaelic, Serbian, Sesotho, Shona, Sindhi, Sinhala, Slovak, Slovenian, Somali, Spanish, Sundanese, Swahili, Swedish, Tajik, Tamil, Tatar, Telugu, Thai, Turkish, Turkmen, Ukrainian, Urdu, Uyghur, Uzbek, Vietnamese, Welsh, Xhosa, Yiddish, Yoruba, Zulu, Language translation.